About this Speaker
Carcinotech is a MedTech company manufacturing 3D printed tumours using patient-derived cancer stem cells, primary cells and established cell lines. Our advanced models provide a platform for rapid, ethical and accurate drug discovery, screening and pre-clinical testing. We work with global partners, leading pharma companies, surgeons, pathologists, clinicians and industry-leaders to accelerate drug discovery and bring more effective cancer treatments to market. Our AI-driven automated manufacturing allows for accelerated production, with models offering high-throughput capabilities. Carcinotech also offers bespoke manufacturing, with clients able to customise the printed tumours according to their testing needs. We are a team of like-minded, highly-experienced and determined individuals, all sharing a vision for success. Learn more about our models, get in touch.